A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

NCT04641273 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

154

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Interventions

DRUG: BAY1817080
DRUG: Placebo for BAY1817080
DRUG: Placebo for Pregabalin
DRUG: Pregabalin

Sponsor

Bayer